Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma.
about
Pathogenesis of thrombotic microangiopathiesA new paradigm: Diagnosis and management of HSCT-associated thrombotic microangiopathy as multi-system endothelial injuryHematopoietic cell transplantation-associated thrombotic microangiopathy: a review of pathophysiology, diagnosis, and treatmentAcute Kidney Injury in Hematopoietic Stem Cell Transplantation: A ReviewTransplant-associated thrombotic microangiopathy: opening Pandora's box.Specific Etiologies Associated With the Multiple Organ Dysfunction Syndrome in Children: Part 1.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants.Prospective study on the behaviour of the metalloprotease ADAMTS13 and of von Willebrand factor after bone marrow transplantation.Thrombotic microangiopathies: an update.Acute renal failure after allogeneic myeloablative stem cell transplantation: retrospective analysis of incidence, risk factors and survival.Evaluation and management of patients with thrombotic thrombocytopenic purpura.Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis.Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria.Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning.Transplantation-associated thrombotic microangiopathy: effect of concomitant GVHD on efficacy of therapeutic plasma exchange.Chronic kidney disease, thrombotic microangiopathy, and hypertension following T cell-depleted hematopoietic stem cell transplantation.Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.Successful early intervention for hyperacute transplant-associated thrombotic microangiopathy following pediatric hematopoietic stem cell transplantation.Evaluation of schistocyte monitoring after haematopoietic stem cell transplantation.Multiple myeloma presenting with a fever of unknown origin and development of thrombotic thrombocytopenic purpura post-bortezomib.Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus.Systemic infections mimicking thrombotic thrombocytopenic purpura.Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation.Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.Thrombotic microangiopathy associated with sirolimus level after allogeneic hematopoietic cell transplantation with tacrolimus/sirolimus-based graft-versus-host disease prophylaxisRisk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus.Hematopoietic stem cell transplant-associated thrombotic microangiopathy: review of pharmacologic treatment options.Outcomes of plasma exchange in patients with transplant-associated thrombotic microangiopathy based on time of presentation since transplant.Fragmented Red Cell as a Possible Favorable Prognostic Marker of Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy.End-stage renal disease from hemolytic uremic syndrome in the United States, 1995-2010The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy.Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.Eculizumab in Transplant-Associated Thrombotic Microangiopathy.Treatment of thrombotic microangiopathy after hematopoietic stem cell transplantation with recombinant human soluble thrombomodulin.Post-bone marrow transplant thrombotic microangiopathy.Treatment with or without plasma exchange for patients with acquired thrombotic microangiopathy not associated with severe ADAMTS13 deficiency: a propensity score-matched study.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Thrombotic microangiopathy in haematopoietic cell transplantation: an update.
P2860
Q24658043-FAF2B0AA-D15C-4785-9647-65E360DCE48FQ26992169-5876DA28-9BC3-4D58-BE9A-38A375706091Q28069228-E6B4844E-91DA-4948-A2B9-DA8545592AA2Q28074157-D08B1552-E631-4DAA-997C-6A3B9EC4CBE1Q30235311-9AE89A80-E6D0-4ADB-8652-2A4E41BCB84EQ30253063-6E09729E-88F6-4D30-BB9A-C65245A5427DQ30276550-A1206883-B571-4DCB-BC70-DBBA4115C3D9Q33368614-7139371C-BA7D-4BEF-AA9E-EFDF60671625Q33371965-D54EE583-2A8D-47ED-BB37-53C969D9DA6BQ33374370-4E425D2A-28ED-447E-9733-13BED0940D93Q33374450-FA14F813-67D2-4047-99F9-2EA0807DA407Q33375004-018D4DC2-34D6-4BB2-8AFE-FEE3EF850BB9Q33375739-69F4F939-B667-4B1E-97CB-ADE2F28A7B29Q33382787-6961B4CA-24DA-4A4C-80A6-ECABAB23BF94Q33384578-3B044879-91F3-4EF9-B0AF-D2E7CCBAC807Q33386036-67EE40E1-68F1-4194-B469-C419A883BC4BQ33386308-C290A5FB-5301-4A17-AF9C-7B30E973E281Q33388255-57200F44-D45F-4F4E-8FEB-F3BB14495405Q33391308-38F80535-8B82-4010-BCF1-A9575FA862FFQ33392710-1961AB8F-96A8-427A-A8C4-2A41F5148356Q33393944-F8042A57-CE87-4191-8C67-FB5EBEE6E7F7Q33394977-E3367CEE-A552-4545-8992-31D732390725Q33395253-ECCC8C7C-60CC-47E4-9144-862E3E0F092EQ33396765-CA87644D-EBB0-451A-B1A7-FC1410387369Q33398627-FC3776EF-2F53-4A16-A2DC-235C7327B41AQ33401403-5B81BFAB-D40F-4EC3-8805-B12E48DFD233Q33403897-F294BEBD-BC73-4E47-AD65-DB8BD03C31A0Q33413498-0F7A6065-C71A-4CBF-90A1-A0EC7F59C526Q33417613-C95F9430-6AFF-4C6C-8DD1-EB196442032DQ33417690-CB928039-9972-42D5-A72A-7A4C4C5A3CB0Q33418635-C232082F-4135-4A69-8042-1745BD036A61Q33420509-5D34E47E-0DC3-49E7-8EC4-01B218D28037Q33424153-85DB4C09-BC95-4BDB-A2C6-3B944FDD5745Q33424902-CA06C3DE-8A6B-41DC-97F1-BA0626AA31B1Q33425079-E0667C70-399D-4B3A-B3BD-A64866D648DAQ33428744-4719D592-FC68-47AA-8AAA-16E5AA32DF75Q33430697-14E2A68D-B3BC-4730-BC8A-6A2CB88D077CQ33432547-8628653A-AC42-4FDE-8C1C-AE96B595AC3AQ34122035-B7867ACC-8731-4FC0-9203-F1804EE6E31CQ35098992-86143D06-AA88-47A4-9EF2-38796FCB3B39
P2860
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Thrombotic thrombocytopenic pu ...... ntation: a diagnostic dilemma.
@ast
Thrombotic thrombocytopenic pu ...... ntation: a diagnostic dilemma.
@en
type
label
Thrombotic thrombocytopenic pu ...... ntation: a diagnostic dilemma.
@ast
Thrombotic thrombocytopenic pu ...... ntation: a diagnostic dilemma.
@en
prefLabel
Thrombotic thrombocytopenic pu ...... ntation: a diagnostic dilemma.
@ast
Thrombotic thrombocytopenic pu ...... ntation: a diagnostic dilemma.
@en
P2093
P2860
P1433
P1476
Thrombotic thrombocytopenic pu ...... ntation: a diagnostic dilemma.
@en
P2093
George B Selby
James N George
Jay R McMinn
Xiaoning Li
P2860
P304
P356
10.1111/J.1537-2995.2004.00700.X
P577
2004-02-01T00:00:00Z